Taken together, we automatically hypothesized that upregulated SLC7A5 and SLC1A5 might contribute to the development of liver fibrosis by suppressing the expression of the immune checkpoint and inducing the anomalous immunocyte activation intrahepatic. The gene discussed is SLC1A5; the disease is Hepatic fibrosis.